Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.27NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.27NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.22NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.7.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.22NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GP.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GP.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GP.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.3.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.3.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.3.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBVNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBVNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBVNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.397NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.277NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.277NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.277NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.294NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.294NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.294NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.81NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.81NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.81NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HV.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HV.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HV.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.2.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.2.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KK.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KK.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.3.17NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.3.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.17NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FG.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FG.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FG.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GN.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GN.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GN.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.1.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used